Capital Flow Monitor · Sponsors · CIK 1806841
GT Biotech Fund, LP
40 S. Main Street, Memphis, TN, 38103 · 901-526-9750
Pooled Investment Fund / Hedge Fund · Limited Partnership· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$233.5M
% sold
—
Investors
314
Min investment
$5K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-29 | D/A ·current | 506(b) | — | $233.5M | — | 314 | EDGAR ↗ |
| 2025-07-29 | D/A | 506(b) | — | $229.3M | — | 304 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- n/a Gerber/Taylor Management LLC — Executive Officer, Memphis, TN
- Michael J. Douglass — Executive Officer, Memphis, TN
- Ryan E. Gibbs — Executive Officer, Memphis, TN
- Mary C. Cornpropst — Executive Officer, Memphis, TN
- Justin L. Rikard — Executive Officer, Memphis, TN
- Simone T. Meeks — Executive Officer, Memphis, TN
- Darren Kearns — Executive Officer, Memphis, TN
Placement agents
- Lion Street Financial, Llc · 18 RE raises
- Amd Capital, Llc · 0 RE raises
- Harbor Financial Services, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.